 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Low Doses of Steroids Improve Survival in Patients with Septic Shock
6 July 2004 | Volume 141 Issue 1 | Page I-64
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
The summary below is from the full report titled "Meta-Analysis: The Effect of Steroids on Survival and Shock during Sepsis Depends on the Dose." It is in the 6 July 2004 issue of Annals of Internal Medicine (volume 141, pages 47-56). The authors are P.C. Minneci, K.J. Deans, S.M. Banks, P.Q. Eichacker, and C. Natanson.
What is the problem and what is known about it so far?
Septic shock is a serious, sometimes fatal, condition that occurs when an overwhelming infection leads to low blood pressure and low blood flow. Doctors have tried several treatments for septic shock. From 1960 to 1990, they sometimes gave people with septic shock infusions of high-dose steroids (glucocorticoids) to try to fight inflammation and help increase blood pressure. Some studies suggested that the high doses actually worsened the body's ability to fight infection. Since 1990, doctors sometimes used lower doses of steroids. Whether the lower doses actually benefit patients is not clear.
Why did the researchers do this particular study?
To determine whether steroids given in particular doses improve survival rates of patients with septic shock.
Who was studied?
1717 patients with sepsis and septic shock who had participated in trials that assessed effects of steroids on survival.
How was the study done?
Rather than performing a new study, the researchers reviewed 14 trials. These trials randomly assigned adult patients with sepsis in intensive care units to receive or not receive infusions of steroids. Nine trials were performed between 1960 and 1990 and 5 trials were performed between 1998 and 2002. The researchers assessed doses and timing of steroids used in the trials. They then compared how many patients survived in the 2 groups of studies.
What did the researchers find?
Trials published before 1990 showed that steroids worsened survival of patients with sepsis. Recent trials showed that steroids improved survival. The recent trials gave steroids in lower doses and for longer periods (about a week) than the earlier trials (several hours to days). Older trials more often started steroid therapy within a few hours of diagnosis, while recent trials more often started steroid therapy 1 to 3 days after diagnosis.
What were the limitations of the study?
Patients with septic shock typically receive several treatments. Treatments other than steroids may have varied between older and newer studies.
What are the implications of the study?
Short courses of high-dose steroids harm patients with sepsis, while 5- to 7-day courses of low-dose steroids benefit patients with sepsis.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  S. Gotoh, N. Nishimura, O. Takahashi, H. Shiratsuka, H. Horinouchi, H. Ono, N. Uchiyama, and N. Chohnabayashi Adrenal function in patients with community-acquired pneumonia Eur. Respir. J., June 1, 2008; 31(6): 1268 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Daley, N. Seam, R. Luboshitzky, G. Qupti, P.-E. Bollaert, P. E. Marik, S. M. Pastores, B. P. Kavanagh, S. Manoach, C. L. Sprung, et al. Corticosteroids for Septic Shock N. Engl. J. Med., May 8, 2008; 358(19): 2068 - 2071. [Full Text] [PDF]
|
|
|
|
|
|
C. L. Sprung, D. Annane, D. Keh, R. Moreno, M. Singer, K. Freivogel, Y. G. Weiss, J. Benbenishty, A. Kalenka, H. Forst, et al. Hydrocortisone Therapy for Patients with Septic Shock N. Engl. J. Med., January 10, 2008; 358(2): 111 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Finfer Corticosteroids in Septic Shock N. Engl. J. Med., January 10, 2008; 358(2): 188 - 190. [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Cotton, O. D. Guillamondegui, S. B. Fleming, R. O. Carpenter, S. H. Patel, J. A. Morris Jr, and P. G. Arbogast Increased Risk of Adrenal Insufficiency Following Etomidate Exposure in Critically Injured Patients Arch Surg, January 1, 2008; 143(1): 62 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Wheeler Recent Developments in the Diagnosis and Management of Severe Sepsis Chest, December 1, 2007; 132(6): 1967 - 1976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Cooper and P. M. Stewart Adrenal Insufficiency in Critical Illness J Intensive Care Med, November 1, 2007; 22(6): 348 - 362. [Abstract] [PDF]
|
|
|
|
 |
|
 J. V. Maier, S. Brema, J. Tuckermann, U. Herzer, M. Klein, M. Stassen, A. Moorthy, and A. C. B. Cato Dual Specificity Phosphatase 1 Knockout Mice Show Enhanced Susceptibility to Anaphylaxis but Are Sensitive to Glucocorticoids Mol. Endocrinol., November 1, 2007; 21(11): 2663 - 2671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. U. Meduri There Is No Illumination in Speculation: Additional Data in Support of Methylprednisolone Treatment in ARDS Chest, September 1, 2007; 132(3): 1097 - 1100. [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Thomas and G. L Fraser An Update on the Diagnosis of Adrenal Insufficiency and the Use of Corticotherapy in Critical Illness Ann. Pharmacother., September 1, 2007; 41(9): 1456 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. U. Meduri, E. Golden, A. X. Freire, E. Taylor, M. Zaman, S. J. Carson, M. Gibson, and R. Umberger Methylprednisolone Infusion in Early Severe ARDS*Results of a Randomized Controlled Trial Chest, April 1, 2007; 131(4): 954 - 963. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. de Kruif, L. C. Lemaire, I. A. Giebelen, M. A. D. van Zoelen, J. M. Pater, P. S. van den Pangaart, A. P. Groot, A. F. de Vos, P. J. Elliott, J. C. M. Meijers, et al. Prednisolone Dose-Dependently Influences Inflammation and Coagulation during Human Endotoxemia J. Immunol., February 1, 2007; 178(3): 1845 - 1851. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Vanhorebeek, R. P. Peeters, S. Vander Perre, I. Jans, P. J. Wouters, K. Skogstrand, T. K. Hansen, R. Bouillon, and G. Van den Berghe Cortisol Response to Critical Illness: Effect of Intensive Insulin Therapy J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3803 - 3813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Suri, J. Moran, J. U. Hibbard, K. Kasza, and R. E. Weiss Assessment of Adrenal Reserve in Pregnancy: Defining the Normal Response to the Adrenocorticotropin Stimulation Test J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3866 - 3872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Marik, D. Annane, C. L. Sprung, W. Arlt, D. Keh, and for the International Task Force on the Diagnoses Using Corticosteroids in Intensive Care Arch Surg, September 1, 2006; 141(9): 946 - 947. [Full Text] [PDF]
|
|
|
|
 |
|
 C. VELLOZZI, T. MITCHELL, E. MILLER, C. G. CASEY, R. B. EIDEX, E. B. HAYES, and THE YELLOW FEVER VACCINE SAFETY WORKING GROUP YELLOW FEVER VACCINE-ASSOCIATED VISCEROTROPIC DISEASE (YEL-AVD) AND CORTICOSTEROID THERAPY: ELEVEN UNITED STATES CASES, 1996-2004. Am J Trop Med Hyg, August 1, 2006; 75(2): 333 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Arlt, F. Hammer, P. Sanning, S. K. Butcher, J. M. Lord, B. Allolio, D. Annane, and P. M. Stewart Dissociation of Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate in Septic Shock J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2548 - 2554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Liu, M. A. Matthay, and G. M. Chertow Evolving Practices in Critical Care and Potential Implications for Management of Acute Kidney Injury Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 869 - 873. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nonas, I. Miller, K. Kawkitinarong, S. Chatchavalvanich, I. Gorshkova, V. N. Bochkov, N. Leitinger, V. Natarajan, J. G. N. Garcia, and K. G. Birukov Oxidized Phospholipids Reduce Vascular Leak and Inflammation in Rat Model of Acute Lung Injury Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1130 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Talwar, P. J. Munson, J. Barb, C. Fiuza, A. P. Cintron, C. Logun, M. Tropea, S. Khan, D. Reda, J. H. Shelhamer, et al. Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans Physiol Genomics, April 13, 2006; 25(2): 203 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Vincent and E. Abraham The Last 100 Years of Sepsis Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 256 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Harrison Prospects for Vaccine Prevention of Meningococcal Infection Clin. Microbiol. Rev., January 1, 2006; 19(1): 142 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Ho, H. Al-Musalhi, M. J. Chapman, T. Quach, P. D. Thomas, C. J. Bagley, J. G. Lewis, and D. J. Torpy Septic Shock and Sepsis: A Comparison of Total and Free Plasma Cortisol Levels J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 105 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wartofsky Update in Endocrinology Ann Intern Med, November 1, 2005; 143(9): 673 - 682. [Full Text] [PDF]
|
|
|
|
|
|
G. U. Meduri, R. Umberger, and M. Confalonieri Hydrocortisone Infusion for Severe Community-acquired Pneumonia: The Role of Relative Adrenal Insufficiency Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 782 - 783. [Full Text] [PDF]
|
|
|
|
|
|
G. Dickstein On the Term "Relative Adrenal Insufficiency"--or What Do We Really Measure with Adrenal Stimulation Tests? J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4973 - 4974. [Full Text] [PDF]
|
|
|
|
 |
|
 ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB Evid. Based Med., April 1, 2005; 10(2): 62 - 62. [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Munford Invited review: Detoxifying endotoxin: time, place and person Innate Immunity, April 1, 2005; 11(2): 69 - 84. [Abstract] [PDF]
|
|
|
|
|
|
M. Confalonieri, R. Urbino, A. Potena, M. Piattella, P. Parigi, G. Puccio, R. Della Porta, C. Giorgio, F. Blasi, R. Umberger, et al. Hydrocortisone Infusion for Severe Community-acquired Pneumonia: A Preliminary Randomized Study Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 242 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N Bower and L. J Oyen Interaction Between Dexamethasone Treatment and the Corticotropin Stimulation Test in Septic Shock Ann. Pharmacother., February 1, 2005; 39(2): 335 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Noble Dose Effects of Steroids on Survival in Sepsis Ann Intern Med, December 7, 2004; 141(11): 891 - 891. [Full Text] [PDF]
|
|
|
|
|
|
R. G. Badgett Dose Effects of Steroids on Survival in Sepsis Ann Intern Med, December 7, 2004; 141(11): 891 - 892. [Full Text] [PDF]
|
|
|
|
|
|
P. C. Minneci, K. J. Deans, S. M. Banks, P. Q. Eichacker, and C. Natanson Corticosteroids for Septic Shock Ann Intern Med, November 2, 2004; 141(9): 742 - 743. [Full Text] [PDF]
|
|
|
|
|
|
Other articles noted Evid. Based Med., November 1, 2004; 9(6): 191 - 192. [Full Text] [PDF]
|
|
|
|
 |
|
 Steroids in Sepsis: The Fog Is Beginning to Lift Journal Watch Emergency Medicine, July 28, 2004; 2004(728): 2 - 2. [Full Text]
|
|
|
|
|
|
J. M. Luce Physicians Should Administer Low-Dose Corticosteroids Selectively to Septic Patients until an Ongoing Trial Is Completed Ann Intern Med, July 6, 2004; 141(1): 70 - 72. [Full Text] [PDF]
|
|
Read all Rapid Responses
| |||||||||||||||||||||||||||||||||||||||||||||||||
Article
